Other Species / Isoforms
  NMDAR2B (mouse)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S31
SKARSQKSAPSIGIA
0 1
NMDAR2B (human) SRARSQKsPPsIGIA S31-p
NMDAR2B (mouse) SKARSQKSAPSIGIA S31
NMDAR2B (rat) SKARSQKSPPSIGIA S31
S34
RSQKSAPSIGIAVIL
0 1
NMDAR2B (human) RSQKsPPsIGIAVIL S34-p
NMDAR2B (mouse) RSQKSAPSIGIAVIL S34
NMDAR2B (rat) RSQKSPPSIGIAVIL S34
N74-ng
RVELVAMnETDPKSI
0 1
NMDAR2B (human) RVELVAMNETDPKSI N74
NMDAR2B (mouse) RVELVAMnETDPKSI N74-ng
NMDAR2B (rat) RVELVAMNETDPKSI N74
Y239
CTKEEATYIFEVANS
0 1
NMDAR2B (human) CTKEEATyIFEVANS Y239-p
NMDAR2B (mouse) CTKEEATYIFEVANS Y239
NMDAR2B (rat) CTKEEATYIFEVANS Y239
Y338
QSNMLNRYLInVTFE
0 1
NMDAR2B (human) QSNMLNRYLINVTFE Y338
NMDAR2B (mouse) QSNMLNRYLInVTFE Y338
NMDAR2B (rat) QSNMLNRyLINVTFE Y338-p
N341-ng
MLNRYLInVTFEGRn
0 1
NMDAR2B (human) MLNRYLINVTFEGRN N341
NMDAR2B (mouse) MLNRYLInVTFEGRn N341-ng
NMDAR2B (rat) MLNRyLINVTFEGRN N341
N348-ng
nVTFEGRnLSFSEDG
0 1
NMDAR2B (human) NVTFEGRNLSFSEDG N348
NMDAR2B (mouse) nVTFEGRnLSFSEDG N348-ng
NMDAR2B (rat) NVTFEGRNLSFSEDG N348
N444-ng
QKRIISEnKTDEEPG
0 1
NMDAR2B (human) QKRIVTENKTDEEPG N444
NMDAR2B (mouse) QKRIISEnKTDEEPG N444-ng
NMDAR2B (rat) QKRIISENKTDEEPG N444
T475
ISKSVKFTYDLYLVT
0 1
NMDAR2B (human) ISKSVKFtYDLYLVT T475-p
NMDAR2B (mouse) ISKSVKFTYDLYLVT T475
NMDAR2B (rat) ISKSVKFTYDLYLVT T475
N491-ng
GKHGKKInGTWNGMI
0 1
NMDAR2B (human) GKHGKKINGtWNGMI N491
NMDAR2B (mouse) GKHGKKInGTWNGMI N491-ng
NMDAR2B (rat) GKHGKKINGTWNGMI N491
T493
HGKKInGTWNGMIGE
0 2
NMDAR2B (human) HGKKINGtWNGMIGE T493-p
NMDAR2B (mouse) HGKKInGTWNGMIGE T493
NMDAR2B (rat) HGKKINGTWNGMIGE T493
T514
YMAVGSLTINEERSE
0 1
NMDAR2B (human) YMAVGSLtINEERSE T514-p
NMDAR2B (mouse) YMAVGSLTINEERSE T514
NMDAR2B (rat) YMAVGSLTINEERSE T514
S720
GVDDALLSLKTGKLD
0 1
NMDAR2B (human) GVDDALLsLKTGKLD S720-p
NMDAR2B (mouse) GVDDALLSLKTGKLD S720
NMDAR2B (rat) GVDDALLSLKTGKLD S720
S759
GSGKVFASTGYGIAI
0 1
NMDAR2B (human) GSGKVFAstGyGIAI S759-p
NMDAR2B (mouse) GSGKVFASTGYGIAI S759
NMDAR2B (rat) GSGKVFASTGYGIAI S759
T760
SGKVFASTGYGIAIQ
0 1
NMDAR2B (human) SGKVFAstGyGIAIQ T760-p
NMDAR2B (mouse) SGKVFASTGYGIAIQ T760
NMDAR2B (rat) SGKVFASTGYGIAIQ T760
Y762
KVFASTGYGIAIQKD
0 1
NMDAR2B (human) KVFAstGyGIAIQKD Y762-p
NMDAR2B (mouse) KVFASTGYGIAIQKD Y762
NMDAR2B (rat) KVFASTGYGIAIQKD Y762
S770
GIAIQKDSGWKRQVD
0 1
NMDAR2B (human) GIAIQKDsGWKRQVD S770-p
NMDAR2B (mouse) GIAIQKDSGWKRQVD S770
NMDAR2B (rat) GIAIQKDSGWKRQVD S770
S855-p
HCFMGVCsGKPGMVF
0 1
NMDAR2B (human) HCFMGVCSGKPGMVF S855
NMDAR2B (mouse) HCFMGVCsGKPGMVF S855-p
NMDAR2B (rat) HCFMGVCSGKPGMVF S855
S865
PGMVFSISRGIYSCI
0 1
NMDAR2B (human) PGMVFSIsRGIYSCI S865-p
NMDAR2B (mouse) PGMVFSISRGIYSCI S865
NMDAR2B (rat) PGMVFSISRGIYSCI S865
S882-p
VAIEERQsVMNsPTA
0 4
NMDAR2B (human) VAIEERQSVMNSPTA S882
NMDAR2B (mouse) VAIEERQsVMNsPTA S882-p
NMDAR2B (rat) VAIEERQsVMNsPTA S882-p
S886-p
ERQsVMNsPTATMNN
1 3
NMDAR2B (human) ERQSVMNSPTATMNN S886
NMDAR2B (mouse) ERQsVMNsPTATMNN S886-p
NMDAR2B (rat) ERQsVMNsPTATMNN S886-p
K906-ub
LRLLRTAkNMANLSG
0 1
NMDAR2B (human) LRLLRTAKNMANLSG K906
NMDAR2B (mouse) LRLLRTAkNMANLSG K906-ub
NMDAR2B (rat) LRLLRTAKNMANLSG K906
S917-p
NLSGVNGsPQsALDF
Upstream
1 7
Treatment
  • long-term_potentiation
NMDAR2B (human) NLSGVNGSPQSALDF S917
NMDAR2B (mouse) NLSGVNGsPQsALDF S917-p
NMDAR2B (rat) NLSGVNGsPQsALDF S917-p
S920-p
GVNGsPQsALDFIRR
0 5
NMDAR2B (human) GVNGSPQSALDFIRR S920
NMDAR2B (mouse) GVNGsPQsALDFIRR S920-p
NMDAR2B (rat) GVNGsPQsALDFIRR S920-p
S929-p
LDFIRREssVyDIsE
1 24
NMDAR2B (human) LDFIRRESSVYDISE S929
NMDAR2B (mouse) LDFIRREssVyDIsE S929-p
NMDAR2B (rat) LDFIRREssVyDIsE S929-p
S930-p
DFIRREssVyDIsEH
1 24
NMDAR2B (human) DFIRRESSVYDISEH S930
NMDAR2B (mouse) DFIRREssVyDIsEH S930-p
NMDAR2B (rat) DFIRREssVyDIsEH S930-p
Y932-p
IRREssVyDIsEHRR
1 56
NMDAR2B (human) IRRESSVYDISEHRR Y932
NMDAR2B (mouse) IRREssVyDIsEHRR Y932-p
NMDAR2B (rat) IRREssVyDIsEHRR Y932-p
S935-p
EssVyDIsEHRRsFT
1 20
NMDAR2B (human) ESSVYDISEHRRSFT S935
NMDAR2B (mouse) EssVyDIsEHRRsFT S935-p
NMDAR2B (rat) EssVyDIsEHRRSFt S935-p
S940-p
DIsEHRRsFTHSDCK
0 1
NMDAR2B (human) DISEHRRSFTHSDCK S940
NMDAR2B (mouse) DIsEHRRsFTHSDCK S940-p
NMDAR2B (rat) DIsEHRRSFtHSDCK S940
T942
sEHRRsFTHSDCKSY
0 1
NMDAR2B (human) SEHRRSFTHSDCKSY T942
NMDAR2B (mouse) sEHRRsFTHSDCKSY T942
NMDAR2B (rat) sEHRRSFtHSDCKsy T942-p
S948
FTHSDCKSYNNPPCE
1 1
NMDAR2B (human) FTHSDCKSYNNPPCE S948
NMDAR2B (mouse) FTHSDCKSYNNPPCE S948
NMDAR2B (rat) FtHSDCKsyNNPPCE S948-p
Y949
THSDCKSYNNPPCEE
1 3
NMDAR2B (human) THSDCKSYNNPPCEE Y949
NMDAR2B (mouse) THSDCKSYNNPPCEE Y949
NMDAR2B (rat) tHSDCKsyNNPPCEE Y949-p
S960
PCEENLFSDyIsEVE
1 3
NMDAR2B (human) PCEENLFSDYISEVE S960
NMDAR2B (mouse) PCEENLFSDyIsEVE S960
NMDAR2B (rat) PCEENLFsDyIsEVE S960-p
Y962-p
EENLFSDyIsEVERT
1 51
NMDAR2B (human) EENLFSDYISEVERT Y962
NMDAR2B (mouse) EENLFSDyIsEVERT Y962-p
NMDAR2B (rat) EENLFsDyIsEVERT Y962-p
S964-p
NLFSDyIsEVERTFG
1 5
NMDAR2B (human) NLFSDYISEVERTFG S964
NMDAR2B (mouse) NLFSDyIsEVERTFG S964-p
NMDAR2B (rat) NLFsDyIsEVERTFG S964-p
S978-p
GNLQLKDsNVYQDHY
0 1
NMDAR2B (human) GNLQLKDSNVYQDHY S978
NMDAR2B (mouse) GNLQLKDsNVYQDHY S978-p
NMDAR2B (rat) GNLQLKDSNVyQDHy S978
Y981
QLKDsNVYQDHYHHH
1 1
NMDAR2B (human) QLKDSNVYQDHYHHH Y981
NMDAR2B (mouse) QLKDsNVYQDHYHHH Y981
NMDAR2B (rat) QLKDSNVyQDHyHHH Y981-p
Y985
sNVYQDHYHHHHRPH
1 1
NMDAR2B (human) SNVYQDHYHHHHRPH Y985
NMDAR2B (mouse) sNVYQDHYHHHHRPH Y985
NMDAR2B (rat) SNVyQDHyHHHHRPH Y985-p
S993
HHHHRPHSIGSTSSI
0 2
NMDAR2B (human) HHHHRPHSIGSASSI S993
NMDAR2B (mouse) HHHHRPHSIGSTSSI S993
NMDAR2B (rat) HHHHRPHsIGSTSSI S993-p
Y1004
TSSIDGLYDCDNPPF
0 3
NMDAR2B (human) ASSIDGLYDCDNPPF Y1004
NMDAR2B (mouse) TSSIDGLYDCDNPPF Y1004
NMDAR2B (rat) TSSIDGLyDCDNPPF Y1004-p
S1017-p
PFTTQPRsIsKkPLD
Upstream
0 1
Treatment
  • long-term_potentiation
NMDAR2B (human) PFTTQSRSISKKPLD S1017
NMDAR2B (mouse) PFTTQPRsIsKkPLD S1017-p
NMDAR2B (rat) PFTTQPRSISKKPLD S1017
S1019-p
TTQPRsIsKkPLDIG
0 1
NMDAR2B (human) TTQSRSISKKPLDIG S1019
NMDAR2B (mouse) TTQPRsIsKkPLDIG S1019-p
NMDAR2B (rat) TTQPRSISKKPLDIG S1019
K1021-ub
QPRsIsKkPLDIGLP
0 1
NMDAR2B (human) QSRSISKKPLDIGLP K1021
NMDAR2B (mouse) QPRsIsKkPLDIGLP K1021-ub
NMDAR2B (rat) QPRSISKKPLDIGLP K1021
S1030
LDIGLPSSkHSQLSD
1 1
NMDAR2B (human) LDIGLPSSKHSQLSD S1030
NMDAR2B (mouse) LDIGLPSSkHSQLSD S1030
NMDAR2B (rat) LDIGLPSsKHsQLsD S1030-p
K1031-ub
DIGLPSSkHSQLSDL
0 1
NMDAR2B (human) DIGLPSSKHSQLSDL K1031
NMDAR2B (mouse) DIGLPSSkHSQLSDL K1031-ub
NMDAR2B (rat) DIGLPSsKHsQLsDL K1031
S1033
GLPSSkHSQLSDLyG
1 9
NMDAR2B (human) GLPSSKHSQLSDLyG S1033
NMDAR2B (mouse) GLPSSkHSQLSDLyG S1033
NMDAR2B (rat) GLPSsKHsQLsDLyG S1033-p
S1036
SSkHSQLSDLyGkFs
1 16
NMDAR2B (human) SSKHSQLSDLyGKFs S1036
NMDAR2B (mouse) SSkHSQLSDLyGkFs S1036
NMDAR2B (rat) SsKHsQLsDLyGKFs S1036-p
Y1039-p
HSQLSDLyGkFsFKS
1 180
NMDAR2B (human) HSQLSDLyGKFsFKS Y1039-p
NMDAR2B (mouse) HSQLSDLyGkFsFKS Y1039-p
NMDAR2B (rat) HsQLsDLyGKFsFKs Y1039-p
K1041-ub
QLSDLyGkFsFKSDR
0 1
NMDAR2B (human) QLSDLyGKFsFKSDR K1041
NMDAR2B (mouse) QLSDLyGkFsFKSDR K1041-ub
NMDAR2B (rat) QLsDLyGKFsFKsDR K1041
S1043-p
SDLyGkFsFKSDRYS
1 13
NMDAR2B (human) SDLyGKFsFKSDRYS S1043-p
NMDAR2B (mouse) SDLyGkFsFKSDRYS S1043-p
NMDAR2B (rat) sDLyGKFsFKsDRys S1043-p
S1046
yGkFsFKSDRYSGHD
0 1
NMDAR2B (human) yGKFsFKSDRYSGHD S1046
NMDAR2B (mouse) yGkFsFKSDRYSGHD S1046
NMDAR2B (rat) yGKFsFKsDRysGHD S1046-p
Y1049
FsFKSDRYSGHDDLI
1 3
NMDAR2B (human) FsFKSDRYSGHDDLI Y1049
NMDAR2B (mouse) FsFKSDRYSGHDDLI Y1049
NMDAR2B (rat) FsFKsDRysGHDDLI Y1049-p
S1050
sFKSDRYSGHDDLIR
1 1
NMDAR2B (human) sFKSDRYSGHDDLIR S1050
NMDAR2B (mouse) sFKSDRYSGHDDLIR S1050
NMDAR2B (rat) sFKsDRysGHDDLIR S1050-p
S1058-p
GHDDLIRsDVSDIST
1 5
NMDAR2B (human) GHDDLIRSDVSDIST S1058
NMDAR2B (mouse) GHDDLIRsDVSDIST S1058-p
NMDAR2B (rat) GHDDLIRsDVsDIst S1058-p
S1061
DLIRsDVSDISTHtV
1 6
NMDAR2B (human) DLIRSDVSDISTHTV S1061
NMDAR2B (mouse) DLIRsDVSDISTHtV S1061
NMDAR2B (rat) DLIRsDVsDIstHtV S1061-p
S1064
RsDVSDISTHtVTyG
1 6
NMDAR2B (human) RSDVSDISTHTVTYG S1064
NMDAR2B (mouse) RsDVSDISTHtVTyG S1064
NMDAR2B (rat) RsDVsDIstHtVtyG S1064-p
T1065
sDVSDISTHtVTyGN
1 4
NMDAR2B (human) SDVSDISTHTVTYGN T1065
NMDAR2B (mouse) sDVSDISTHtVTyGN T1065
NMDAR2B (rat) sDVsDIstHtVtyGN T1065-p
T1067-p
VSDISTHtVTyGNIE
1 6
NMDAR2B (human) VSDISTHTVTYGNIE T1067
NMDAR2B (mouse) VSDISTHtVTyGNIE T1067-p
NMDAR2B (rat) VsDIstHtVtyGNIE T1067-p
T1069
DISTHtVTyGNIEGN
1 3
NMDAR2B (human) DISTHTVTYGNIEGN T1069
NMDAR2B (mouse) DISTHtVTyGNIEGN T1069
NMDAR2B (rat) DIstHtVtyGNIEGN T1069-p
Y1070-p
ISTHtVTyGNIEGNA
Upstream
Downstream
2 138
NMDAR2B (human)
Y1070-p
NMDAR2B (mouse)
Y1070-p
NMDAR2B (rat)
Y1070-p
Effects on Modified Protein
  • molecular association, regulation
  • phosphorylation
Kinase, in vitro:
  • Fyn (human)
Putative in vivo kinases:
  • FRK (mouse)
Treatment
  • long-term_potentiation
NMDAR2B (human) ISTHTVTYGNIEGNA Y1070
NMDAR2B (mouse) ISTHtVTyGNIEGNA Y1070-p
NMDAR2B (rat) IstHtVtyGNIEGNA Y1070-p
S1088-p
RKQQYKDsLKKRPAS
0 1
NMDAR2B (human) RKQQYKDSLKKRPAS S1088
NMDAR2B (mouse) RKQQYKDsLKKRPAS S1088-p
NMDAR2B (rat) RKQQYKDSLKKRPAS S1088
Y1109-p
FDEIELAyRRRPPRs
1 54
NMDAR2B (human) FDEIELAYRRRPPRS Y1109
NMDAR2B (mouse) FDEIELAyRRRPPRs Y1109-p
NMDAR2B (rat) FDEIELAyRRRPPRs Y1109-p
S1116-p
yRRRPPRsPDHKRYF
Upstream
Downstream
1 4
Effects on Modified Protein
  • receptor internalization, induced
Kinase, in vitro:
  • CDK5 (mouse)
Putative in vivo kinases:
  • CDK5 (mouse)
Treatment
  • long-term_potentiation
NMDAR2B (human) YRRRPPRSPDHKRYF S1116
NMDAR2B (mouse) yRRRPPRsPDHKRYF S1116-p
NMDAR2B (rat) yRRRPPRsPDHKRYF S1116-p
K1126-ub
HKRYFRDkEGLRDFY
0 1
NMDAR2B (human) HKRYFRDKEGLRDFY K1126
NMDAR2B (mouse) HKRYFRDkEGLRDFY K1126-ub
NMDAR2B (rat) HKRYFRDKEGLRDFy K1126
Y1133
kEGLRDFYLDQFRTK
1 29
NMDAR2B (human) KEGLRDFYLDQFRTK Y1133
NMDAR2B (mouse) kEGLRDFYLDQFRTK Y1133
NMDAR2B (rat) KEGLRDFyLDQFRtK Y1133-p
T1139
FYLDQFRTKENsPHW
0 1
NMDAR2B (human) FYLDQFRTKENSPHW T1139
NMDAR2B (mouse) FYLDQFRTKENsPHW T1139
NMDAR2B (rat) FyLDQFRtKENsPHW T1139-p
S1143-p
QFRTKENsPHWEHVD
1 17
NMDAR2B (human) QFRTKENSPHWEHVD S1143
NMDAR2B (mouse) QFRTKENsPHWEHVD S1143-p
NMDAR2B (rat) QFRtKENsPHWEHVD S1143-p
T1152
HWEHVDLTDIyKERS
0 1
NMDAR2B (human) HWEHVDLTDIYKERS T1152
NMDAR2B (mouse) HWEHVDLTDIyKERS T1152
NMDAR2B (rat) HWEHVDLtDIyKERS T1152-p
Y1155-p
HVDLTDIyKERSDDF
1 56
NMDAR2B (human) HVDLTDIYKERSDDF Y1155
NMDAR2B (mouse) HVDLTDIyKERSDDF Y1155-p
NMDAR2B (rat) HVDLtDIyKERSDDF Y1155-p
S1166-p
SDDFKRDsVSGGGPC
Upstream
3 3
Treatment
  • baclofen
  • colforsin
  • guanfacine
  • H-89
NMDAR2B (human) SDDFKRDsVsGGGPC S1166-p
NMDAR2B (mouse) SDDFKRDsVSGGGPC S1166-p
NMDAR2B (rat) SDDFKRDsVSGGGPC S1166-p
S1168
DFKRDsVSGGGPCTN
0 1
NMDAR2B (human) DFKRDsVsGGGPCTN S1168-p
NMDAR2B (mouse) DFKRDsVSGGGPCTN S1168
NMDAR2B (rat) DFKRDsVSGGGPCTN S1168
T1183
RSHLKHGTGDKHGVV
0 1
NMDAR2B (human) RSHIKHGtGDKHGVV T1183-p
NMDAR2B (mouse) RSHLKHGTGDKHGVV T1183
NMDAR2B (rat) RSHLKHGTGEKHGVV T1183
G1191
GDKHGVVGGVPAPWE
0 2
NMDAR2B (human) GDKHGVVsGVPAPWE S1191-p
NMDAR2B (mouse) GDKHGVVGGVPAPWE G1191
NMDAR2B (rat) GEKHGVVGGVPAPWE G1191
K1221
FCRSCPSKLHNySST
0 2
NMDAR2B (human) FCRSCPSKLHNYSTT K1221
NMDAR2B (mouse) FCRSCPSKLHNySST K1221
NMDAR2B (rat) FCRSCPSkLHNysst K1221-ub
Y1225-p
CPSKLHNySSTVAGQ
1 78
NMDAR2B (human) CPSKLHNYSTTVTGQ Y1225
NMDAR2B (mouse) CPSKLHNySSTVAGQ Y1225-p
NMDAR2B (rat) CPSkLHNysstVAGQ Y1225-p
S1226
PSKLHNySSTVAGQN
1 2
NMDAR2B (human) PSKLHNYSTTVTGQN S1226
NMDAR2B (mouse) PSKLHNySSTVAGQN S1226
NMDAR2B (rat) PSkLHNysstVAGQN S1226-p
S1227
SKLHNySSTVAGQNs
1 2
NMDAR2B (human) SKLHNYSTTVTGQNS T1227
NMDAR2B (mouse) SKLHNySSTVAGQNs S1227
NMDAR2B (rat) SkLHNysstVAGQNS S1227-p
T1228
KLHNySSTVAGQNsG
0 1
NMDAR2B (human) KLHNYSTTVTGQNSG T1228
NMDAR2B (mouse) KLHNySSTVAGQNsG T1228
NMDAR2B (rat) kLHNysstVAGQNSG T1228-p
S1234-p
STVAGQNsGRQACIR
0 1
NMDAR2B (human) TTVTGQNSGRQACIR S1234
NMDAR2B (mouse) STVAGQNsGRQACIR S1234-p
NMDAR2B (rat) stVAGQNSGRQACIR S1234
Y1252-p
CKKAGNLyDIsEDNs
Upstream
2 7
Putative in vivo kinases:
  • Fyn (mouse)
Treatment
  • ephrin_B2
NMDAR2B (human) CKKAGNLYDISEDNS Y1252
NMDAR2B (mouse) CKKAGNLyDIsEDNs Y1252-p
NMDAR2B (rat) CKKAGNLyDIsEDNs Y1252-p
S1255-p
AGNLyDIsEDNsLQE
0 3
NMDAR2B (human) AGNLYDISEDNSLQE S1255
NMDAR2B (mouse) AGNLyDIsEDNsLQE S1255-p
NMDAR2B (rat) AGNLyDIsEDNsLQE S1255-p
S1259-p
yDIsEDNsLQELDQP
0 5
NMDAR2B (human) YDISEDNSLQELDQP S1259
NMDAR2B (mouse) yDIsEDNsLQELDQP S1259-p
NMDAR2B (rat) yDIsEDNsLQELDQP S1259-p
K1280
SSNASTTKYPQsPtN
0 1
NMDAR2B (human) TSNASTTkYPQSPTN K1280-ac
NMDAR2B (mouse) SSNASTTKYPQsPtN K1280
NMDAR2B (rat) TSNASSTKYPQSPTN K1280
S1284-p
STTKYPQsPtNSKAQ
0 2
NMDAR2B (human)
S1284-p
NMDAR2B (mouse)
S1284-p
NMDAR2B (rat)
S1284-p
NMDAR2B (human) STTkYPQSPTNSkAQ S1284
NMDAR2B (mouse) STTKYPQsPtNSKAQ S1284-p
NMDAR2B (rat) SSTKYPQSPTNSKAQ S1284
T1286-p
TKYPQsPtNSKAQKK
0 2
NMDAR2B (human) TkYPQSPTNSkAQKK T1286
NMDAR2B (mouse) TKYPQsPtNSKAQKK T1286-p
NMDAR2B (rat) TKYPQSPTNSKAQKK T1286
K1289
PQsPtNSKAQKKNRN
0 1
NMDAR2B (human) PQSPTNSkAQKKNRN K1289-ac
NMDAR2B (mouse) PQsPtNSKAQKKNRN K1289
NMDAR2B (rat) PQSPTNSKAQKKNRN K1289
S1303-p
NKLRRQHsyDtFVDL
Upstream
Downstream
36 42
Effects on Modified Protein
  • activity, induced
  • molecular association, regulation
Putative in vivo kinases:
  • DAPK1 (mouse)
Regulatory protein:
  • DAPK1 (mouse)
Treatment
  • bicuculline
  • deoxygenation
  • long-term depression
  • long-term_potentiation
  • NMDA
  • propofol
  • SKF81297
NMDAR2B (human) NKLRRQHsyDtFVDL S1303-p
NMDAR2B (mouse) NKLRRQHsyDtFVDL S1303-p
NMDAR2B (rat) NKLRRQHsyDtFVDL S1303-p
Y1304-p
KLRRQHsyDtFVDLQ
1 35
NMDAR2B (human) KLRRQHsyDtFVDLQ Y1304-p
NMDAR2B (mouse) KLRRQHsyDtFVDLQ Y1304-p
NMDAR2B (rat) KLRRQHsyDtFVDLQ Y1304-p
T1306-p
RRQHsyDtFVDLQKE
1 15
NMDAR2B (human) RRQHsyDtFVDLQKE T1306-p
NMDAR2B (mouse) RRQHsyDtFVDLQKE T1306-p
NMDAR2B (rat) RRQHsyDtFVDLQKE T1306-p
S1323-p
ALAPRSVsLKDKGRF
3 1
NMDAR2B (human) ALAPRSVsLKDKGRF S1323-p
NMDAR2B (mouse) ALAPRSVsLKDKGRF S1323-p
NMDAR2B (rat) ALAPRSVsLKDKGRF S1323-p
S1334-p
KGRFMDGsPyAHMFE
1 3
NMDAR2B (human) KGRFMDGSPYAHMFE S1334
NMDAR2B (mouse) KGRFMDGsPyAHMFE S1334-p
NMDAR2B (rat) KGRFMDGsPyAHMFE S1334-p
Y1336-p
RFMDGsPyAHMFEMP
Upstream
6 8
Putative in vivo kinases:
  • Fyn (mouse)
Treatment
  • ephrin_B2
NMDAR2B (human) RFMDGSPYAHMFEMS Y1336
NMDAR2B (mouse) RFMDGsPyAHMFEMP Y1336-p
NMDAR2B (rat) RFMDGsPyAHMFEMP Y1336-p
S1367
HHHNNPGSGyMLSKS
1 2
NMDAR2B (human) HHHNNPGGGYMLSKS G1369
NMDAR2B (mouse) HHHNNPGSGyMLSKS S1367
NMDAR2B (rat) HHHNNPGsGyMLSKS S1367-p
Y1369-p
HNNPGSGyMLSKSLY
1 11
NMDAR2B (human) HNNPGGGYMLSKSLY Y1371
NMDAR2B (mouse) HNNPGSGyMLSKSLY Y1369-p
NMDAR2B (rat) HNNPGsGyMLSKSLY Y1369-p
K1400
QCLLHGSKSYFFRQP
0 1
NMDAR2B (human) QCLLHGSKSYFFRQP K1402
NMDAR2B (mouse) QCLLHGSKSYFFRQP K1400
NMDAR2B (rat) QCLLHGSkSyFFRQP K1400-ub
Y1402
LLHGSKSYFFRQPTV
0 1
NMDAR2B (human) LLHGSKSYFFRQPtV Y1404
NMDAR2B (mouse) LLHGSKSYFFRQPTV Y1402
NMDAR2B (rat) LLHGSkSyFFRQPTV Y1402-p
T1408
SYFFRQPTVAGASKT
0 1
NMDAR2B (human) SYFFRQPtVAGASKA T1410-p
NMDAR2B (mouse) SYFFRQPTVAGASKT T1408
NMDAR2B (rat) SyFFRQPTVAGASKT T1408
K1426-ac
FRALVTNkPVVSALH
0 1
NMDAR2B (human) FRALVTNKPVVsALH K1428
NMDAR2B (mouse) FRALVTNkPVVSALH K1426-ac
NMDAR2B (rat) FRALVTNKPVVVTLH K1426
K1426-ub
FRALVTNkPVVSALH
0 1
NMDAR2B (human) FRALVTNKPVVsALH K1428
NMDAR2B (mouse) FRALVTNkPVVSALH K1426-ub
NMDAR2B (rat) FRALVTNKPVVVTLH K1426
S1430
VTNkPVVSALHGAVP
0 1
NMDAR2B (human) VTNKPVVsALHGAVP S1432-p
NMDAR2B (mouse) VTNkPVVSALHGAVP S1430
NMDAR2B (rat) VTNKPVVVTLHGAVP V1430
K1458-ub
NPCVPNNkNPRAFNG
0 2
NMDAR2B (human) NPCVPNNKNPRAFNG K1460
NMDAR2B (mouse) NPCVPNNkNPRAFNG K1458-ub
NMDAR2B (rat) NPCVPNNKNPRAFNG K1458
S1467
PRAFNGSSNGHVyEK
0 1
NMDAR2B (human) PRAFNGSsNGHVyEK S1469-p
NMDAR2B (mouse) PRAFNGSSNGHVyEK S1467
NMDAR2B (rat) PRAFNGSSNGHVyEK S1467
Y1472-p
GSSNGHVyEKLSSIE
Upstream
Downstream
28 105
NMDAR2B (human)
Y1474-p
NMDAR2B (mouse)
Y1472-p
NMDAR2B (rat)
Y1472-p
Effects on Modified Protein
  • activity, induced
  • intracellular localization
  • phosphorylation
  • receptor internalization, altered
Putative in vivo kinases:
  • Fyn (mouse)
  • Src (mouse)
Putative upstream phosphatases:
  • STEP (mouse)
Regulatory protein:
  • CDK5 (human)
  • PSD-95 (human)
Treatment
  • activin
  • beta-amyloid
  • colforsin
  • electrical_stimulation
  • EP1-selective_antagonist
  • ephrin_B2
  • forced swim test
  • Freund's_complete_adjuvant
  • H-89
  • indometacin
  • ketamine
  • PP2
  • seliciclib
  • SU6656
NMDAR2B (human) GSsNGHVyEKLSSIE Y1474-p
NMDAR2B (mouse) GSSNGHVyEKLSSIE Y1472-p
NMDAR2B (rat) GSSNGHVyEKLssIE Y1472-p
S1476
GHVyEKLSSIEsDV_
0 1
NMDAR2B (human) GHVyEKLSSIESDV_ S1478
NMDAR2B (mouse) GHVyEKLSSIEsDV_ S1476
NMDAR2B (rat) GHVyEKLssIEsDV_ S1476-p
S1477
HVyEKLSSIEsDV__
0 1
NMDAR2B (human) HVyEKLSSIESDV__ S1479
NMDAR2B (mouse) HVyEKLSSIEsDV__ S1477
NMDAR2B (rat) HVyEKLssIEsDV__ S1477-p
S1480-p
EKLSSIEsDV_____
Upstream
2 1
Treatment
  • propofol
NMDAR2B (human) EKLSSIESDV_____ S1482
NMDAR2B (mouse) EKLSSIEsDV_____ S1480-p
NMDAR2B (rat) EKLssIEsDV_____ S1480-p